Description

KLOW is a multi-peptide research formulation combining BPC-157, GHK-Cu, TB500, and KPV across several areas of cellular and tissue research. BPC-157 is investigated in tissue response and cellular signalling, GHK-Cu in copper-associated and collagen-related pathways, while TB500 is researched in cellular migration and recovery-related mechanisms. KPV adds another area of interest within peptide and cellular research. Together, these compounds provide researchers with a broad formulation for studying interacting biological pathways under controlled experimental conditions. KLOW contains 10mg each of BPC-157, TB500, and KPV, plus 50mg GHK-Cu, totalling 80mg across 10 vials.